Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz K D, Binder V
Department of Medical Gastroenterology C, Herlev Hospital, University of Copenhagen, Denmark.
Gut. 1994 Jan;35(1):68-72. doi: 10.1136/gut.35.1.68.
Increased intestinal permeability in patients with Crohn's disease and their first degree relatives has been proposed as an aetiological factor. The nine hour overnight urinary excretion of polyethyleneglycol-400 (PEG-400) and three inert sugars (lactulose, l-rhamnose, and mannitol) was used to test the permeation in 47 patients with Crohn's disease of whom 18 had at least one first degree relative with inflammatory bowel disease (2BD) and 52 patients with ulcerative colitis of whom 16 had at least one first degree relative with IBD. A total of 17 first degree relatives with IBD and 56 healthy first degree relatives were included. Thirty one healthy subjects not related to patients with IBD served as controls. No significant differences in PEG-400 permeation were found between the groups of patients, relatives, and controls, or between diseased and healthy relatives. The permeability to lactulose, rhamnose, and mannitol similarly did not differ between the three groups. This study challenges the previously reported findings of increased PEG-400 permeation in patients with Crohn's disease and in their healthy and diseased first degree relatives. There was no increase in permeability in a similar group of ulcerative colitis patients and their families.
克罗恩病患者及其一级亲属肠道通透性增加被认为是一个病因学因素。采用聚乙二醇-400(PEG-400)及三种惰性糖(乳果糖、L-鼠李糖和甘露醇)的9小时夜间尿排泄量来检测47例克罗恩病患者(其中18例至少有一位患有炎症性肠病(IBD)的一级亲属)以及52例溃疡性结肠炎患者(其中16例至少有一位患有IBD的一级亲属)的通透性。总共纳入了17例患有IBD的一级亲属和56例健康的一级亲属。31名与IBD患者无亲属关系的健康受试者作为对照。在患者组、亲属组和对照组之间,以及患病亲属和健康亲属之间,未发现PEG-400通透性存在显著差异。三组之间乳果糖、鼠李糖和甘露醇的通透性同样没有差异。本研究对先前报道的克罗恩病患者及其患病和健康的一级亲属中PEG-400通透性增加的结果提出了质疑。在一组类似的溃疡性结肠炎患者及其家族中,通透性并未增加。